Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Prostate Cancer
|
July 30, 2019
Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States"
Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, et al.
Prostate Cancer
|
March 20, 2019
Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States
Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, et al.
Endocrinology
|
July 1, 1995
The reduced responsiveness of cultured bovine parathyroid cells to extracellular Ca2+ is associated with marked reduction in the expression of extracellular Ca(2+)-sensing receptor messenger ribonucleic acid and protein
A Mithal, O Kifor, I Kifor, et al.
The Journal of Biological Chemistry
|
July 18, 2013
A Ca2+-dependent mechanism of neuronal survival mediated by the microtubule-associated protein p600
Camille Belzil, Gernot Neumayer, Alex P Vassilev, et al.
Future Oncology (London, England)
|
June 10, 2020
Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countries
Zdravko P Vassilev, Montse Soriano Gabarró, James A Kaye, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
July 23, 2005
Case of elevated blood lead in a South Asian family that has used Sindoor for food coloring
Zdravko P Vassilev, Steven M Marcus, Karpukarasi Ayyanathan, et al.
Pharmaceutical Medicine
|
January 15, 2020
Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization Measures
Laurie J Zografos, Elizabeth Andrews, Daniel L Wolin, et al.
Pharmaceutical Medicine
|
January 15, 2020
Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures
Laurie J Zografos, Elizabeth Andrews, Dan L Wolin, et al.
Bone Marrow Transplantation
|
October 25, 2011
Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas
V R Paralkar, S D Nasta, K Morrissey, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Prostate Cancer
|
July 30, 2019
Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States"
Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, et al.
Prostate Cancer
|
March 20, 2019
Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States
Catherine W Saltus, Zdravko P Vassilev, Jihong Zong, et al.
Endocrinology
|
July 1, 1995
The reduced responsiveness of cultured bovine parathyroid cells to extracellular Ca2+ is associated with marked reduction in the expression of extracellular Ca(2+)-sensing receptor messenger ribonucleic acid and protein
A Mithal, O Kifor, I Kifor, et al.
The Journal of Biological Chemistry
|
July 18, 2013
A Ca2+-dependent mechanism of neuronal survival mediated by the microtubule-associated protein p600
Camille Belzil, Gernot Neumayer, Alex P Vassilev, et al.
Future Oncology (London, England)
|
June 10, 2020
Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countries
Zdravko P Vassilev, Montse Soriano Gabarró, James A Kaye, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
July 23, 2005
Case of elevated blood lead in a South Asian family that has used Sindoor for food coloring
Zdravko P Vassilev, Steven M Marcus, Karpukarasi Ayyanathan, et al.
Pharmaceutical Medicine
|
January 15, 2020
Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization Measures
Laurie J Zografos, Elizabeth Andrews, Daniel L Wolin, et al.
Pharmaceutical Medicine
|
January 15, 2020
Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures
Laurie J Zografos, Elizabeth Andrews, Dan L Wolin, et al.
Bone Marrow Transplantation
|
October 25, 2011
Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas
V R Paralkar, S D Nasta, K Morrissey, et al.
Page
of 6